Ascendis Pharma A/S (ASND)
NASDAQ: ASND · Real-Time Price · USD
261.00
+1.20 (0.46%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Ascendis Pharma Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Bank of America Securities | Bank of America Securities | Buy Reiterates $288 → $306 | Buy | Reiterates | $288 → $306 | +17.24% | Jul 14, 2026 |
| Wedbush | Wedbush | Buy Reiterates $273 → $327 | Buy | Reiterates | $273 → $327 | +25.29% | Jul 9, 2026 |
| Barclays | Barclays | Buy Maintains $345 | Buy | Maintains | $345 | +32.18% | Jul 8, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $275 → $280 | Buy | Maintains | $275 → $280 | +7.28% | Jul 7, 2026 |
| J.P. Morgan | J.P. Morgan | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 18, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $450 → $326 | Buy | Maintains | $450 → $326 | +24.90% | Jun 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Reiterates $262 | Buy | Reiterates | $262 | +0.38% | Jun 15, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates $305 | Buy | Reiterates | $305 | +16.86% | Jun 2, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.